ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    The Need for Diabetic Medications after Pancreas Transplantation

    A. Bhansali, O. El Shamy, M. Menon, R. Shapiro, V. Delaney, G. De Boccardo

    Mount Sinai Hospital, New York, NY

    *Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…
  • 2019 American Transplant Congress

    Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)

    T. Janaudis-Ferreira1, S. Mathur2, R. Deliva3, N. Howes4, C. Patterson5, A. Räkel6, S. So5, L. Wickerson7, M. White6, Y. Avitzur5, O. Johnston8, N. Heywood9, S. Singh7, S. Holdsworth10

    1School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada, 2University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4London Health Sciences Centre, London, ON, Canada, 5The Hospital For Sick Children, Toronto, ON, Canada, 6University of Montreal Hospital Centre, Montreal, QC, Canada, 7University Health Network, Toronto, ON, Canada, 8Vancouver General Hospital, Vancouver, BC, Canada, 9McGill University Health Centre, Montreal, QC, Canada, 10Canadian Donation and Transplantation Research Program, Edmonton, AB, Canada

    *Purpose: Exercise training has been shown to be beneficial across several chronic disease groups that may lead to solid organ transplantation (SOT), and across organ…
  • 2019 American Transplant Congress

    A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients

    J. Langlee, L. Lees, A. Saha, D. Helfer, M. Waldram, A. Love, F. Rivera, A. Massie, D. Segev, D. Brennan, M. Henderson

    Johns Hopkins School of Medicine, Baltimore, MD

    *Purpose: The leading predictor of rejection, de novo DSA, graft loss, and death among adult kidney transplant (KT) recipients is immunosuppressive medication nonadherence. An estimated…
  • 2019 American Transplant Congress

    Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis

    A. Chewcharat1, C. Thongprayoon2, B. Boonpheng3, A. Torres-Ortiz4, M. A Mao2, N. J Khoury5, W. Cheungpasitporn4

    1Harvard T.H. Chan, Boston, MA, 2Mayo Clinic, Rochester, MN, 3East Tennessee State University, Johnson City, TN, 4University of Mississippi Medical Center, Jackson, MS, 5Henry Ford Hospital, Detroit, MI

    *Purpose: The incidence and mortality of renal cell carcinoma (RCC) after kidney transplantation (KTx) remain unclear. This study's aims were 1) to investigate the pooled…
  • 2019 American Transplant Congress

    Paradoxical Liver Simulated Allocation Model (LSAM) Projections for Changes to Waitlist Mortality under Acuity Circle Distribution Model

    R. Lynch1, K. Ross1, S. Karp2

    1Emory, Atlanta, GA, 2Vanderbilt, Nashville, TN

    *Purpose: In December 2018, the United Network for Organ Sharing (UNOS) board voted to change liver transplant distribution from Donor Service Areas (DSAs) to a…
  • 2019 American Transplant Congress

    Mycophenolate Mofetil versus Azathioprine in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression: The ATHENA Trial

    P. Cravedi1, P. Ruggenenti2, E. Gotti2, A. Plati2, S. Sandrini3, N. Bossini3, F. Citterio4, E. Minetti5, D. Montanaro6, R. Tardanico3, E. Sabadini2, F. Gaspari7, A. Villa7, F. Peraro7, G. Remuzzi7

    1Mount Sinai, New York, NY, 2ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy, 3ASST degli Spedali Civili, Brescia, Italy, 4Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, 5ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, 6Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy, 7Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

    *Purpose: Registration trials using old sandimmune formulation of cyclosporine (CsA) led to the general idea that Mycophenolate Mofetil (MMF) prevents acute cellular rejection (ACR) more…
  • 2019 American Transplant Congress

    The Pregnancy Experiences of Uterus Transplant Recipients

    A. E. Wall, L. Johannesson, G. Testa, A. Warren

    Baylor University Medical Center, Dallas, TX

    *Purpose: The purpose of this study was to explore the pregnancy experiences of uterus transplant recipients through semi-structured interviews so as to develop a better…
  • 2019 American Transplant Congress

    Challenges to Inpatient Management Post Abdominal Wall Transplant (AWT) – From App’s Perspective

    K. Hattori, D. Sudan, K. Ravindra

    Duke University hospital, Durham, NC

    *Purpose: To highlight the unique features of caring for an AWT recipient and identify areas of improvement for future cases*Methods: AWT is an innovative adjunct…
  • 2019 American Transplant Congress

    MHC Cross-Dressing in Mixed Hematopoietic Chimerism

    B. Gonzalez Nolasco1, M. Wang1, W. Orent1, A. Prunevieille1, K. Pruner1, J. O1, J. Paster1, J. C. Madsen2, G. Benichou1

    1Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Department of Surgery, Center for Transplantation Sciences, Division of Cardiac Surgery, Massachusetts General Hospital, Boston, MA

    *Purpose: Achieving specific long-term allograft survival without ongoing immunosuppression is one of the main objectives in transplantation. Mixed hematopoietic chimerism is a strategy that has…
  • 2019 American Transplant Congress

    Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells

    A. A. Duizendstra1, R. J. Knegt de1, M. G. Betjes2, M. P. Peppelenbosch1, N. H. Litjens2, J. Kwekkeboom1

    1Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands, 2Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands

    *Purpose: Lifelong treatment with immunosuppressive drugs (IS) to prevent graft rejection in transplant recipients is accompanied by side effects. Some recipients are considered to be…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences